Global and Multidimensional Symptom Assessments in Patients Presenting Abdominal Neoplasms

Ana Lucia Lira Pessoa de Souza; Thalyta Cássia de Freitas Martins; Thais Martins Pedrosa; Daniela Guimarães Ferreira da Silva; Marianne Regina Silva Potengy de Mello; Camila Drumond Muzi; Raphael Mendonça Guimarães

doi:10.5294/aqui.2019.19.1.4

Authors

Ana Lucia Lira Pessoa de Souza Author Enfermeira Residente, Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro, Brasil. http://orcid.org/0000-0002-8810-9937
Thalyta Cássia de Freitas Martins Author Enfermeira Residente, Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro, Brasil. http://orcid.org/0000-0002-6225-7245
Thais Martins Pedrosa Author Enfermeira Residente, Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro, Brasil. http://orcid.org/0000-0001-7199-6157
Daniela Guimarães Ferreira da Silva Author Enfermeira Residente, Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro, Brasil http://orcid.org/0000-0001-9296-7486
Marianne Regina Silva Potengy de Mello Author Bolsista de Iniciação Científica, Universidade Federal do Estado do Rio de Janeiro. Rio de Janeiro, Brasil. http://orcid.org/0000-0001-9364-1656
Camila Drumond Muzi Author Tecnologista Pleno, Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro, Brasil. http://orcid.org/0000-0002-5567-0437
Raphael Mendonça Guimarães Author Pesquisador em Saúde Pública. Fundação Oswaldo Cruz. Rio de Janeiro, Brasil. http://orcid.org/0000-0003-1225-6719

DOI:

https://doi.org/10.5294/aqui.2019.19.1.4

Keywords:

Symptom assessment, medical oncology, abdominal neoplasms, surveys and questionnaires, signs and symptoms

Abstract

Avaliação global e miltidimensional de sintomas em pacientes com neoplasias abdominais

Evaluación global y multidimensional de síntomas en pacientes con neoplasias abdominales

Objective: To evaluate symptoms among patients with abdominal cancer and associated factors. Materials and methods: A cross-sectional study with 100 patients. The prevalence of symptoms was evaluated through the Memorial Symptom Assessment Scale (MSAS) and its association with demographic and clinical variables using chi-square and ANOVA tests. Results: The most prevalent symptoms were weight loss (64.0 %), pain (56.0 %), dry mouth (50.0 %), “I do not look more myself” (48.0 %) and lack of energy (45.0 %). There was a significant difference between sex and high-frequency (PHYS-H) (p = 0.001) and low-frequency (PHYS-L) physical symptoms (p = 0.004), and for general scale (TMSAS) (p = 0.002); (p = 0.001), general range (p = 0.027) and borderline significance for the global scale (GDI) (p = 0.051); high-frequency physical symptoms (p = 0.022), low-frequency physical symptoms (p = 0.034) and the overall scale (p = 0.034). There was one major complaint regarding the severity of high-frequency physical symptoms in patients with liver cancer (p = 0.018). Conclusion: Symptoms of physical and psychological aspects in cancer patients were associated with gender, race, marital status and tumor location. There is a need for tools to assess symptoms and enable health professionals to intervene more effectively.

To reference this article / Para citar este artículo / Para citar este artigo

Lira AL, de Freitas TC, Martins T, Guimarães D, Silva MR, Drumond C, Guimarães RM. Global and Multidimensional Symptom Assessments in Patients Presenting Abdominal Neoplasms. Aquichan 2019; 19(1): e1914. DOI: 10.5294/aqui.2019.19.1.4

Received: 15/07/2018

Approved: 15/01/2019

Downloads

Download data is not yet available.

References

Bray F, Colombet M, Mery L, Piсeros M, Znaor A, Zanetti R, et al., editors. Cancer incidence in five continents. Vol. XI (electronic version). Lyon: International Agency for Research on Cancer; 2017. Available from: http://ci5.iarc.fr

Bray F, Ferlay J, Soerjomataram I, Siegel, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394-424. doi: 10.3322/caac.21492

Instituto Nacional de Cвncer Josй Alencar Gomes da Silva. Estimativa 2018: incidкncia de cвncer no Brasil. Rio de Janeiro: INCA; 2017.

Fisher P. Cancer and quality of life. Homeopathy. 2016; 105(4): 287-88. DOI: 10.1016/j.homp.2016.11.001

Lavdaniti M, Fradelos EC, Troxoutsou K, Zioga E, Mitsi D, Alikari V, et al. Symptoms in advanced cancer patients in a Greek hospital: a descriptive study. Asian Pac J Cancer Prev. 2018; 19(4): 1047-52. doi: 10.22034/APJCP.2018.19.4.1047

Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004; 32: 76-8. DOI: 10.1093/jncimonographs/lgh008

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A(9): 1326-36. DOI: 10.1016/0959-8049(94)90182-1

Rocha LF, Carvalho MS, Lacerda AAML, Viana AFV, Ramos RS, Guimarães RM, et al. Equivalência semântica da versão em português do instrumento Memorial Symptom Assessment Scale (MSAS) para avaliar sintomas em pacientes oncológicos. Rev Bras Pesqui Saъde. 2017; 19(2): 83-91. Available from: http://periodicos.ufes.br/RBPS/article/view/20584

Menezes JR, Luvisaro BMO, Rodrigues CF, Muzi CD, Guimarães RM. Confiabilidade teste-reteste da versão brasileira do instrumento Memorial Symptom Assessment Scale para avaliação de sintomas em pacientes oncológicos. Einstein. 2017; 15(2): 148-54. DOI: 10.1590/s1679-45082017ao3645

Park SA, Chung SH, Lee Y. Factors inﬂuencing the quality of life of patients with advanced cancer. Appl Nurs Res. 2017; 33: 108-12. doi: 10.1016/j.apnr.2016.10.002

Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage. 2003; 25(5): 420-29. DOI: 10.1016/S0885-3924(03)00074-5

Kolankiewicz A, Domenico E, Lopes LF, Magnago T. Validaзгo do inventбrio de sintomas do MD Anderson Cancer Center para a lнngua portuguesa. Rev Esc Enferm USP . 2014; 48(6): 999-1005. doi: 10.1590/S0080-623420140000700006

Dunn J, Ng SK, Holland J, Aitken J, Youl P, Baade PD, et al.. Trajectories of psychological distress after colorectal cancer. Psychooncology. 2013; 22(8): 1759-65. doi: 10.1002/pon.3210

Chih-Yi V, Sarna L. Symptom management in hepatocellular carcinoma. Clin J Oncol Nurs. 2008; 12(5): 759-66. DOI: 10.1188/08.CJON.759-766

Naik A , Uy N , Anaya D, Moye J. The effects of age, education, and treatment on physical, sexual and body concern symptoms among multimorbid, colorectal cancer survivors. J Geriatr Oncol. 2015; 6(4): 299-306. doi: 10.1016/j.jgo.2015.04.001

Ferreira K, William Jr WN, Mendonza TR, Kimura M, Kowalski LP, Rosenthal DI, et al. Tradução para a língua portuguesa do MD Anderson Symptom Inventory head and neck module (MDASIH&N). Rev Bras Cir Cabeça Pescoço. 2008; 37(2): 109-13. doi: 10.1590/S0080-623420140000700006

Kwekkeboom KL. Cancer symptom cluster management. Semin Oncol Nurs. 2016; 32(4): 373-82. doi: 10.1016/j.soncn.2016.08.004

Boeira SF, Guimarães RM, Acioli LR, Stipp MAC. Cluster de sintomas e câncer na pesquisa em enfermagem: revisão sistemática. Rev Bras Cancerol. 2014; 60(4): 351-61. Available from: http://www1.inca.gov.br/rbc/n_60/v04/pdf/10-revisao-de-literatura-cluster-de-sintomas-e-cancer-na-pesquisa-em-enfermagem-revisao-sistematica.pdf

Cooley ME, Siefert ML. Assessment of multiple co-occurring cancer symptoms in the clinical setting. Semin Oncol Nurs. 2016; 32(4): 361-72. doi: 10.1016/j.soncn.2016.08.003

Kenzik KM. Health care use during cancer survivorship: review of 5 years of evidence. Cancer. 2018; (Epub ahead of print). DOI: 10.1002/cncr.3185